BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31116377)

  • 21. Effect of Incorporation of Pretreatment Serum Carcinoembryonic Antigen Levels Into AJCC Staging for Colon Cancer on 5-Year Survival.
    Thirunavukarasu P; Talati C; Munjal S; Attwood K; Edge SB; Francescutti V
    JAMA Surg; 2015 Aug; 150(8):747-755. PubMed ID: 26083632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of age on thyroid cancer staging.
    Kazaure HS; Roman SA; Sosa JA
    Curr Opin Endocrinol Diabetes Obes; 2018 Oct; 25(5):330-334. PubMed ID: 30048260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of BMI on clinical progress, response to treatment, and disease course in patients with differentiated thyroid cancer.
    Gąsior-Perczak D; Pałyga I; Szymonek M; Kowalik A; Walczyk A; Kopczyński J; Lizis-Kolus K; Trybek T; Mikina E; Szyska-Skrobot D; Gadawska-Juszczyk K; Hurej S; Szczodry A; Słuszniak A; Słuszniak J; Mężyk R; Góźdź S; Kowalska A
    PLoS One; 2018; 13(10):e0204668. PubMed ID: 30273371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of the eighth edition AJCC TNM classification for differentiated thyroid carcinoma.
    Kim TH; Kim YN; Kim HI; Park SY; Choe JH; Kim JH; Kim JS; Oh YL; Hahn SY; Shin JH; Kim K; Jeong JG; Kim SW; Chung JH
    Oral Oncol; 2017 Aug; 71():81-86. PubMed ID: 28688696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel analysis of prognosis of young patients with stage II differentiated thyroid cancer based on AJCC 8.0 and 6.0 criteria to implement the staging system.
    Huang Y; Zhou L; Zeng W; Chen S; Zhou W; Wei W; Zhang C; Hu D; Wang M; Liu Z; Guo L
    Gland Surg; 2020 Oct; 9(5):1244-1257. PubMed ID: 33224799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stage migration with the new American Joint Committee on Cancer (AJCC) staging system (8th edition) for differentiated thyroid cancer.
    Shaha AR; Migliacci JC; Nixon IJ; Wang LY; Wong RJ; Morris LGT; Patel SG; Shah JP; Tuttle RM; Ganly I
    Surgery; 2019 Jan; 165(1):6-11. PubMed ID: 30415873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Restaging of differentiated thyroid carcinoma by the sixth edition AJCC/UICC TNM staging system: stage migration and predictability.
    Lang B; Lo CY; Chan WF; Lam KY; Wan KY
    Ann Surg Oncol; 2007 May; 14(5):1551-9. PubMed ID: 17318278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of the Union for International Cancer Control/American Joint Committee on Cancer Tumour, Node, Metastasis system version 8 on staging of differentiated thyroid cancer: a comparison to version 7.
    Verburg FA; Mäder U; Luster M; Reiners C
    Clin Endocrinol (Oxf); 2018 Jun; 88(6):950-956. PubMed ID: 29573277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic indicators in well-differentiated thyroid carcinoma when controlling for stage and treatment.
    Krook KA; Fedewa SA; Chen AY
    Laryngoscope; 2015 Apr; 125(4):1021-7. PubMed ID: 25583017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. No significant difference in the prognostic value of the 5th and 7th editions of AJCC staging for differentiated thyroid cancer.
    Vrachimis A; Gerss J; Stoyke M; Wittekind C; Maier T; Wenning C; Rahbar K; Schober O; Riemann B
    Clin Endocrinol (Oxf); 2014 Jun; 80(6):911-7. PubMed ID: 24417487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of HPV Status on the Prognostic Potential of the AJCC Staging System for Larynx Cancer.
    Davidson SM; Ko HC; Harari PM; Wieland AM; Chen S; Baschnagel AM; Kimple RJ; Witek ME
    Otolaryngol Head Neck Surg; 2018 Sep; 159(3):456-465. PubMed ID: 29611770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of the sixth edition AJCC/UICC TNM classification for differentiated thyroid carcinoma with extrathyroid extension.
    Wada N; Nakayama H; Suganuma N; Masudo Y; Rino Y; Masuda M; Imada T
    J Clin Endocrinol Metab; 2007 Jan; 92(1):215-8. PubMed ID: 17077130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of evidence-based guidelines reduces radioactive iodine treatment in patients with low-risk differentiated thyroid cancer.
    Sacks W; Wong RM; Bresee C; Braunstein GD
    Thyroid; 2015 Apr; 25(4):377-85. PubMed ID: 25578116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcome prediction with the revised American joint committee on cancer staging system and American thyroid association guidelines for thyroid cancer.
    Suh S; Kim YH; Goh TS; Lee J; Jeong DC; Oh SO; Hong JC; Kim SJ; Kim IJ; Pak K
    Endocrine; 2017 Dec; 58(3):495-502. PubMed ID: 29030773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disease Severity at Presentation in Patients with Disease-Related Mortality from Differentiated Thyroid Cancer: Implications for the 2015 ATA Guidelines.
    Robenshtok E; Nachalon Y; Benbassat C; Hirsch D; Shimon I; Grossman A; Diker-Cohen T; Akirov A; Popovtzer A
    Thyroid; 2017 Sep; 27(9):1171-1176. PubMed ID: 28791923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survival Analysis of Papillary Thyroid Carcinoma in Relation to Stage and Recurrence Risk: A 20-Year Experience in Pakistan.
    Hassan A; Razi M; Riaz S; Khalid M; Nawaz MK; Syed AA; Bashir H
    Clin Nucl Med; 2016 Aug; 41(8):606-13. PubMed ID: 27124680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predicting recurrence of papillary thyroid cancer using the eighth edition of the AJCC/UICC staging system.
    Chereau N; Oyekunle TO; Zambeli-Ljepović A; Kazaure HS; Roman SA; Menegaux F; Sosa JA
    Br J Surg; 2019 Jun; 106(7):889-897. PubMed ID: 31012500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of the external validity of the American Joint Committee on Cancer 8th staging system for anal carcinoma.
    Oweira H; Giryes A; Mannhart M; Decker M; Schlumpf R; Abdel-Rahman O
    Curr Med Res Opin; 2018 May; 34(5):923-929. PubMed ID: 29448859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of Timeliness of Resection and Thyroidectomy Margin Status on Survival for Patients with Anaplastic Thyroid Cancer: An Analysis of 335 Cases.
    Goffredo P; Thomas SM; Adam MA; Sosa JA; Roman SA
    Ann Surg Oncol; 2015 Dec; 22(13):4166-74. PubMed ID: 26271394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of the change from the seventh to eighth edition of the AJCC TNM classification of malignant tumours and comparison with the MACIS prognostic scoring system in non-medullary thyroid cancer.
    Dwamena S; Patel N; Egan R; Stechman M; Scott-Coombes D
    BJS Open; 2019 Oct; 3(5):623-628. PubMed ID: 31592514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.